Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
7.19
-0.05 (-0.69%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Zevra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
39044527215830848
Upgrade
Market Cap Growth
63.82%63.82%71.57%-48.52%536.60%283.47%
Upgrade
Enterprise Value
38041623397178112
Upgrade
Last Close Price
7.208.346.554.598.7111.20
Upgrade
Forward PE
94.43----2.95
Upgrade
PS Ratio
14.1018.859.9015.5910.743.64
Upgrade
PB Ratio
9.7411.224.392.112.42-0.73
Upgrade
P/TBV Ratio
---2.112.42-
Upgrade
P/FCF Ratio
----29.76-
Upgrade
P/OCF Ratio
----29.47-
Upgrade
EV/Sales Ratio
16.1117.618.499.526.218.43
Upgrade
EV/EBITDA Ratio
----22.27-
Upgrade
EV/EBIT Ratio
----23.01-
Upgrade
EV/FCF Ratio
----17.20-
Upgrade
Debt / Equity Ratio
1.521.520.710.190.01-1.06
Upgrade
Debt / EBITDA Ratio
----0.18-
Upgrade
Debt / FCF Ratio
----0.16-
Upgrade
Asset Turnover
0.140.140.190.080.401.22
Upgrade
Quick Ratio
2.352.351.167.5826.920.90
Upgrade
Current Ratio
2.532.531.187.7227.201.11
Upgrade
Return on Equity (ROE)
-207.84%-207.84%-67.23%-26.48%-28.18%-
Upgrade
Return on Assets (ROA)
-31.03%-31.03%-21.55%-12.54%6.70%-27.52%
Upgrade
Return on Capital (ROIC)
-52.90%-52.90%-31.82%-14.28%7.27%-62.18%
Upgrade
Return on Capital Employed (ROCE)
----6.00%-
Upgrade
Earnings Yield
-27.08%-23.70%-16.95%-16.90%-2.78%-26.41%
Upgrade
FCF Yield
-17.88%-15.65%-12.45%-11.88%3.36%-4.08%
Upgrade
Buyback Yield / Dilution
-30.46%-30.46%-2.79%-15.87%-647.72%-114.79%
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q